UCB SA (UCBJY)
119.58
-0.16
(-0.13%)
USD |
OTCM |
Sep 18, 16:00
UCB Price : 119.58 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 120.92 | 120.92 | 119.12 | 119.58 | 41735.00 |
| Sep 17, 2026 | 118.93 | 120.56 | 118.93 | 119.74 | 63038.00 |
| Sep 16, 2026 | 120.10 | 120.87 | 117.84 | 118.09 | 42258.00 |
| Sep 15, 2026 | 120.18 | 121.18 | 119.84 | 120.99 | 67402.00 |
| Sep 14, 2026 | 121.48 | 122.03 | 120.76 | 121.42 | 71965.00 |
| Sep 11, 2026 | 121.54 | 121.61 | 119.20 | 119.35 | 59276.00 |
| Sep 10, 2026 | 116.53 | 118.02 | 116.49 | 117.06 | 102242.0 |
| Sep 09, 2026 | 118.74 | 119.71 | 118.62 | 118.67 | 39757.00 |
| Sep 08, 2026 | 121.12 | 121.30 | 120.03 | 120.06 | 46077.00 |
| Sep 04, 2026 | 124.06 | 124.26 | 122.33 | 122.38 | 23697.00 |
| Sep 03, 2026 | 128.57 | 128.75 | 127.00 | 128.58 | 41362.00 |
| Sep 02, 2026 | 127.30 | 128.72 | 127.30 | 127.69 | 25816.00 |
| Sep 01, 2026 | 128.03 | 128.04 | 126.10 | 126.22 | 32805.00 |
| Aug 31, 2026 | 124.56 | 125.03 | 124.54 | 124.96 | 81500.00 |
| Aug 28, 2026 | 126.69 | 126.69 | 125.00 | 125.28 | 20642.00 |
| Aug 27, 2026 | 128.66 | 129.60 | 128.18 | 128.83 | 46629.00 |
| Aug 26, 2026 | 128.02 | 129.05 | 127.44 | 128.49 | 19106.00 |
| Aug 25, 2026 | 130.21 | 131.13 | 130.21 | 130.83 | 48204.00 |
| Aug 24, 2026 | 128.91 | 128.91 | 127.95 | 128.50 | 62815.00 |
| Aug 21, 2026 | 127.28 | 129.56 | 127.28 | 129.23 | 38869.00 |
| Aug 20, 2026 | 127.14 | 127.42 | 124.88 | 126.10 | 49295.00 |
| Aug 19, 2026 | 127.23 | 128.28 | 126.99 | 128.04 | 29647.00 |
| Aug 18, 2026 | 124.55 | 126.00 | 124.42 | 126.00 | 22405.00 |
| Aug 17, 2026 | 124.12 | 125.11 | 124.12 | 124.41 | 39286.00 |
| Aug 14, 2026 | 123.73 | 123.73 | 122.54 | 122.60 | 26717.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1152.93 |
| AstraZeneca PLC | 166.08 |
| Corcept Therapeutics, Inc. | 110.29 |
| Jazz Pharmaceuticals Plc | 240.74 |
| Novo Nordisk A/S | 43.24 |
Price Related Metrics
| PE Ratio | 18.14 |
| PS Ratio | 4.668 |
| PEG Ratio | 0.0203 |
| Price to Free Cash Flow | 32.97 |
| Earnings Yield | 5.51% |
| Market Cap | 45.60B |
| PEGY Ratio | 0.0203 |
| Operating PE Ratio | 14.67 |
| Normalized PE Ratio | 17.98 |